Jin Medical International Ltd. (ZJYL) Financial Ratios
7 years of historical data (2018–2024) · Healthcare · Medical - Instruments & Supplies
EV/EBITDA
↑
87.30
↓-95% vs avg
5yr avg: 1605.25
P/FCF
N/A
—
5yr avg: 1134.92
P/B Ratio
↑
12.06
↓-94% vs avg
5yr avg: 218.23
30Y Low141.6·High141.6
ROE
↓
14.0%
↑-21% vs avg
5yr avg: 17.8%
30Y Low14%·High41%
Debt/EBITDA
↑
2.91
↑+67% vs avg
5yr avg: 1.74
30Y Low0.2·High2.9
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
ZJYL Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Jin Medical International Ltd. trades at 93.6x earnings, 95% below its 5-year average of 1735.6x, sitting at the 50th percentile of its historical range. Compared to the Healthcare sector median P/E of 22.3x, the stock trades at a premium of 319%.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Market Cap | $344M | $8.4B | $3.4B | — | — | — | — | — |
| Enterprise Value | $348M | $8.4B | $3.4B | — | — | — | — | — |
| P/E Ratio → | 93.62 | 2289.36 | 1181.82 | — | — | — | — | — |
| P/S Ratio | 14.65 | 358.20 | 171.34 | — | — | — | — | — |
| P/B Ratio | 12.06 | 294.84 | 141.63 | — | — | — | — | — |
| P/FCF | — | — | 1134.92 | — | — | — | — | — |
| P/OCF | — | — | 1093.29 | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
ZJYL EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
Jin Medical International Ltd.'s enterprise value stands at 87.3x EBITDA, 95% below its 5-year average of 1605.2x. The Healthcare sector median is 14.4x, placing the stock at a 507% premium on an enterprise-value basis.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 358.34 | 171.20 | — | — | — | — | — |
| EV / EBITDA | 87.30 | 2113.43 | 1097.06 | — | — | — | — | — |
| EV / EBIT | 95.60 | 2314.47 | 1183.49 | — | — | — | — | — |
| EV / FCF | — | — | 1133.98 | — | — | — | — | — |
ZJYL Profitability
Margins and return-on-capital ratios measuring operating efficiency
Jin Medical International Ltd. earns an operating margin of 15.5%. Operating margins have expanded from 11.1% to 15.5% over the past 3 years, signaling improving operational efficiency. ROE of 14.0% is modest. ROIC of 10.3% represents solid returns on invested capital.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 40.4% | 40.4% | 34.2% | 32.3% | 30.6% | 34.0% | 36.9% | 36.6% |
| Operating Margin | 15.5% | 15.5% | 14.5% | 11.1% | 12.7% | 14.5% | 21.6% | 20.2% |
| Net Profit Margin | 15.6% | 15.6% | 14.5% | 14.1% | 12.7% | 13.6% | 17.9% | 17.6% |
Return on Capital
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| ROE | 14.0% | 14.0% | 14.7% | 18.5% | 21.2% | 20.5% | 37.0% | 40.9% |
| ROA | 9.3% | 9.3% | 10.7% | 12.6% | 12.3% | 10.7% | 18.7% | 19.7% |
| ROIC | 10.3% | 10.3% | 13.6% | 15.4% | 17.8% | 15.1% | 32.2% | 35.8% |
| ROCE | 13.8% | 13.8% | 14.6% | 14.6% | 21.2% | 21.9% | 44.7% | 47.0% |
ZJYL Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Jin Medical International Ltd. carries a Debt/EBITDA ratio of 2.9x, which is moderately leveraged (11% below the sector average of 3.3x). Net debt stands at $3M ($12M total debt minus $8M cash).
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.41 | 0.41 | 0.17 | — | — | 0.25 | 0.27 | 0.08 |
| Debt / EBITDA | 2.91 | 2.91 | 1.33 | — | — | 0.99 | 0.60 | 0.16 |
| Net Debt / Equity | — | 0.12 | -0.12 | -0.31 | -0.26 | 0.09 | 0.09 | -0.02 |
| Net Debt / EBITDA | 0.87 | 0.87 | -0.91 | -1.93 | -1.24 | 0.37 | 0.20 | -0.03 |
| Debt / FCF | — | — | -0.94 | -3.11 | -0.63 | 0.42 | — | — |
| Interest Coverage | — | — | — | — | 277.23 | 20.95 | 192.76 | — |
ZJYL Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
Jin Medical International Ltd.'s current ratio of 2.50x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The quick ratio of 2.08x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has declined from 3.31x to 2.50x over the past 3 years.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.50 | 2.50 | 3.49 | 3.31 | 2.47 | 1.81 | 1.83 | 1.61 |
| Quick Ratio | 2.08 | 2.08 | 2.83 | 2.11 | 1.57 | 1.09 | 1.24 | 0.99 |
| Cash Ratio | 1.56 | 1.56 | 1.87 | 1.24 | 0.73 | 0.28 | 0.35 | 0.25 |
| Asset Turnover | — | 0.51 | 0.60 | 0.92 | 0.95 | 0.78 | 1.00 | 1.12 |
| Inventory Turnover | 1.97 | 1.97 | 2.23 | 1.89 | 2.05 | 1.47 | 2.24 | 2.19 |
| Days Sales Outstanding | — | 136.29 | 156.53 | 80.87 | 105.11 | 177.19 | 154.59 | 110.70 |
ZJYL Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Jin Medical International Ltd. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business. The earnings yield of 1.1% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 1.1% | 0.0% | 0.1% | — | — | — | — | — |
| FCF Yield | — | — | 0.1% | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | — | — | — | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | — | — | — | — | — |
| Shares Outstanding | — | $156M | $145M | $135M | $268M | $400M | $400M | $400M |
Peer Comparison
Compare ZJYL with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 ZJYLYou | $344M | 93.6 | 87.3 | — | 40.4% | 15.5% | 14.0% | 10.3% | 2.9 |
 MPWR | $77B | 123.6 | 97.9 | 116.2 | 55.2% | 26.1% | 18.4% | 22.2% | 0.0 |
 NVCR | $2B | -13.8 | — | — | 74.5% | -23.5% | -38.9% | -16.4% | — |
 LFUS | $11B | -152.3 | 83.2 | 30.3 | 38.0% | 1.6% | -3.0% | 1.0% | 6.8 |
 GKOS | $8B | -40.9 | — | — | 77.5% | -17.1% | -26.4% | -9.2% | — |
 INVA | $2B | 6.9 | 8.1 | 9.9 | 72.3% | 38.5% | 29.1% | 14.2% | 1.3 |
 OSUR | $225M | -3.3 | — | — | 41.9% | -59.2% | -18.3% | -20.0% | — |
 LMAT | $2B | 42.8 | 33.4 | 33.0 | 71.5% | 27.2% | 15.8% | 9.7% | 2.4 |
 ATRC | $1B | -115.8 | 77.7 | 29.2 | 74.4% | -0.6% | -2.4% | -0.6% | 5.2 |
 MDT | $100B | 21.6 | 14.3 | 19.3 | 65.3% | 17.8% | 9.4% | 6.0% | 3.2 |
 SYK | $113B | 35.0 | 20.3 | 26.3 | 64.0% | 19.5% | 15.1% | 11.4% | 2.4 |
| Healthcare Median | — | 22.3 | 14.4 | 18.5 | 63.9% | -5.2% | -33.7% | -11.2% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 7 years · Updated daily
See ZJYL's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ZJYL Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ZJYL vs MPWR
Side-by-side business, growth, and profitability comparison vs Monolithic Power Systems, Inc..
Start ComparisonZJYL — Frequently Asked Questions
Quick answers to the most common questions about buying ZJYL stock.
What is Jin Medical International Ltd.'s P/E ratio?
Jin Medical International Ltd.'s current P/E ratio is 93.6x. This places it at the 50th percentile of its historical range.
What is Jin Medical International Ltd.'s EV/EBITDA?
Jin Medical International Ltd.'s current EV/EBITDA is 87.3x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA.
What is Jin Medical International Ltd.'s ROE?
Jin Medical International Ltd.'s return on equity (ROE) is 14.0%. The historical average is 23.8%.
Is ZJYL stock overvalued?
Based on historical data, Jin Medical International Ltd. is trading at a P/E of 93.6x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are Jin Medical International Ltd.'s profit margins?
Jin Medical International Ltd. has 40.4% gross margin and 15.5% operating margin. Operating margin between 10-20% is typical for established companies.
How much debt does Jin Medical International Ltd. have?
Jin Medical International Ltd.'s Debt/EBITDA ratio is 2.9x, indicating moderate leverage. A ratio between 2-4x is manageable but warrants monitoring.